Jack Davis

Biography

Jack Davis is Director and Chairman, BioMarker Strategies. He brings more than forty years of experience forming and leading companies in the molecular diagnostics, pathology, and clinical laboratory industries. Mr. Davis has a track record of success bringing breakthrough technologies and tests to the market for the benefit of cancer patients.

Research Interest

Mr. Davis’ professional career includes serving as a co-founder, President/COO and later CEO, and Chairman of Dianon Systems, Inc., which he helped build from a venture capital backed start-up to a leading provider of Clinical and Anatomic Pathology based solutions for clinicians. Dianon was purchased by LabCorp in 2003 for $600 m.  In addition, he served as President and CEO of Calypte Biomedical, a biodiagnostics company that developed the first urine-based HIV test, where he shepherded the company through its IPO.  Previously, he was the Division Vice President and General Manager of the $100 m worldwide Diagnostic Products business unit of Abbott Diagnostics.